ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0751

Accessing Telehealth and In-Person Healthcare During the COVID-19 Pandemic: Experiences of Individuals with Rheumatoid Arthritis

Smruthi Ramachandran1, Jenny Leese2, Stephanie Therrien3, Catherine L. Backman1, Jasmin Ma4, Kelly English5, Eileen Davidson6, Shanon McQuitty7, Alison Hoens5, Cheryl Koehn8, James Gavin9, jo Adams9 and Linda Li1, 1University of British Columbia, Vancouver, BC, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Arthritis Research Canada/University of British Columbia, Richmond, BC, Canada, 5Arthritis Patient Advisory Board of Arthritis Research Canada, Vancouver, BC, Canada, 6Arthritis Patient Advisory Board of Arthritis Research Canada, Burnaby, BC, Canada, 7Arthritis Patient Advisory Board of Arthritis Research Canada, Richmond, BC, Canada, 8Arthritis Consumer Experts, Vancouver, BC, Canada, 9University of Southampton, Southampton, United Kingdom

Meeting: ACR Convergence 2022

Keywords: Access to care, COVID-19, Health Care, Qualitative Research, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: The COVID-19 pandemic has provided opportunity to increase integration of virtual healthcare with in-person medical practices. Individuals with rheumatoid arthritis (RA) continue to self-manage their illness while navigating the period of uncertainty in health service delivery systems. Telehealth options for the management of arthritis during the pandemic were uneven, as systems were developed and providers trained to use them. Understanding individuals’ experiences will inform the integration of telehealth into routine practice post-pandemic. One aim of our qualitative study was to explore the experiences of individuals with RA accessing telehealth and in-person care.

Methods: The study was jointly designed and conducted with patient partners living with RA. Between December 2020 and December 2021, we conducted one-to-one semi-structured interviews (30-70 mins) with participants with RA. Participants were purposively sampled from an ongoing randomized controlled trial (RCT) testing a web-based self-management intervention. Participants eligible for the RCT had: 1) a physician confirmed diagnosis of RA; 2) no joint surgery in the past 6 months; 3) no history of acute injury to any joints in the past six months; 4) an email address and daily access to a computer or mobile device. In the present qualitative study, we aimed for maximum variation in age, sex, and education, within the limits of RCT sample. A collaborative and reflexive thematic analysis approach was used.

Results: Thirty-nine participants (aged 26-86; 36 females; 13 diagnosed with RA between 2019 – 2021) were interviewed. Approximately two thirds held a university degree or above. Three preliminary themes were identified: 1) Deciding between telehealth and in-person: Many individuals preferred telehealth under certain conditions (e.g., to renew medication, to avoid travelling for appointments). Others favoured in-person consultations for ease of explaining symptoms and signs during a physical assessment; 2) Assessing risk of in-person visits: When in-person consultations were preferred, some feared contracting COVID-19 during or on their way to the consult while others felt safe with the health measures in place; and 3) Adapting to systemic disruptions: Some participants struggled with accessing care as health service delivery changed during the pandemic; patients’ in-person appointments were switched to virtual or cancelled without discussion. Others were forced to be flexible given the suspension of in-person clinical care (e.g., receiving a consult outside in the rain).

Conclusion: Our interviews offer nuanced insight into the experiences of individuals with RA seeking health services during the pandemic. People with RA appreciate having a choice between telehealth and in-person consults to best meet their needs, are cautious about accessing health services in-person, and are forced to adjust to obstacles in accessing healthcare. Understanding these perspectives help inform the use of telehealth beyond the pandemic by addressing patient concerns, personalizing telehealth options, and efficiently integrating telehealth into clinical practice for routine check-ups.


Disclosures: S. Ramachandran, None; J. Leese, None; S. Therrien, None; C. Backman, None; J. Ma, None; K. English, None; E. Davidson, None; S. McQuitty, None; A. Hoens, None; C. Koehn, None; J. Gavin, None; j. Adams, None; L. Li, None.

To cite this abstract in AMA style:

Ramachandran S, Leese J, Therrien S, Backman C, Ma J, English K, Davidson E, McQuitty S, Hoens A, Koehn C, Gavin J, Adams j, Li L. Accessing Telehealth and In-Person Healthcare During the COVID-19 Pandemic: Experiences of Individuals with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/accessing-telehealth-and-in-person-healthcare-during-the-covid-19-pandemic-experiences-of-individuals-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accessing-telehealth-and-in-person-healthcare-during-the-covid-19-pandemic-experiences-of-individuals-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology